pAbmAbs

This idea behind pAbmAbs is to share antibody experiences – good and bad – with the scientific community. Each year labs around the globe spend fortunes on commercial research antibodies that do not work as promised by the companies. By sharing this information the research community can potentially save billions of $ each year – and spend time on making scientific progress instead of testing useless antibodies.

The pAbmAbs-site is the second iteration of the site, a brush-up pointing in the direction of a more comprehensive solution already on the drawing board.

Kollision are strategic sparring partners on the concept and development plan as well as design- and development partners on the web platform.